TGFB1 and neoplasm: TME consists of immune cells, including myeloid-derived suppressor cells (MDSCs), Tregs, and tumor-associated macrophages (TAMs), and molecular factors, including checkpoint inhibitory proteins, IL-10, and TGF-β, that inhibit anti-tumor functions of CAR-T cells [152].